MedTrace Logo

Transcutaneous Auricular Vagus Nerve Stimulation in Spinal Cord Injury

NCT05852379 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-05-17

No results posted yet for this study

Summary

This study is a single blinded prospective randomized monocentric study examining the effectiveness of transcutaneous auricular vagus nerve stimulation paired with rehabilitation and low frequency/antidromic stimulation of the pelvic somatic nerves. The investigator hypothesize that treatment using transcutaneous auricular vagus nerve stimulation will improve gait recovery in spinal cord injured participants already treating by rehabilitation and pelvic nerves neuromodulation.

Conditions

Interventions

DEVICE

active taVNS

Transcutaneous auricular vague nerve stimulation

DEVICE

sham taVNS

Scham transcutaneous auricular vague nerve stimulation

Sponsors & Collaborators

  • Possover International Medical Center AG

    lead OTHER

Principal Investigators

  • Marc MP Possover, MD, PhD · Possover International Medical Center AG - Klausstrasse 4, CH-8002 Zürich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-12-31
Completion
2024-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05852379 on ClinicalTrials.gov